| Q34708747 | A combination of two electrophoretical approaches for detailed proteome-based characterization of SCLC subtypes |
| Q34200303 | A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma |
| Q35004607 | Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression. |
| Q36027109 | Automated PGP9.5 immunofluorescence staining: a valuable tool in the assessment of small fiber neuropathy? |
| Q37703387 | Bronchial airway gene expression in smokers with lung or head and neck cancer |
| Q36715039 | Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids. |
| Q33920324 | Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: a study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer |
| Q38123912 | Clinical neuropathology practice guide 5-2013: markers of neuronal maturation |
| Q34058385 | Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma. |
| Q36300261 | DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer |
| Q36136842 | Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype |
| Q39533559 | Frequent CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in sporadic and hereditary Tunisian breast cancer patients: clinical significance |
| Q37824622 | Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications |
| Q30317812 | Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma |
| Q38250190 | Immunocytochemical markers of neuronal maturation in human diagnostic neuropathology |
| Q39611471 | NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression |
| Q87363127 | Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer |
| Q38565170 | Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma |
| Q39727817 | Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer |
| Q43570380 | Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients |
| Q57105884 | Prostate cancer tissues with positive TMPRSS2-ERG-gene-fusion status may display enhanced nerve density |
| Q38071897 | Review of the alterations in DNA methylation in esophageal squamous cell carcinoma |
| Q38019157 | Role of DNA methylation in head and neck cancer |
| Q36221083 | The diagnosis value of promoter methylation of UCHL1 in the serum for progression of gastric cancer |
| Q89638568 | UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer |
| Q36464299 | UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma |
| Q64063558 | UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells |
| Q34228778 | Ubiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions |
| Q33799710 | Ubiquitin C-terminal hydrolase-L1 protects cystic fibrosis transmembrane conductance regulator from early stages of proteasomal degradation |
| Q85843041 | Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors |
| Q39019302 | Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation |
| Q47592158 | Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications |
| Q37481100 | Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma |